San Diego, CA, United States of America

Lisa S Millar

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocept, Inc.. Active years: 2016.


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Lisa S Millar

Introduction

Lisa S Millar is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of molecular and cellular assays through her innovative work. With a focus on enhancing signal amplification, her inventions have the potential to impact various scientific applications.

Latest Patents

Lisa holds a patent for "Methods and reagents for signal amplification." This invention provides reagents containing binding moieties conjugated to dextran moieties. It also outlines methods for making such reagents and their use in a variety of molecular and cellular assays. This patent showcases her expertise and dedication to advancing scientific research.

Career Highlights

Lisa is currently employed at Biocept, Inc., where she continues to develop innovative solutions in the field of biotechnology. Her work at Biocept has allowed her to collaborate with other talented professionals, including her coworker Stephen D Mikolajczyk. Together, they contribute to the company's mission of improving patient outcomes through advanced diagnostic technologies.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Lisa S Millar's contributions to the field of biotechnology through her patent and work at Biocept, Inc. highlight her role as a leading inventor in her area of expertise. Her innovative approaches continue to pave the way for advancements in molecular and cellular assays.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…